GC
ACHV icon

Guggenheim Capital’s Achieve Life Sciences ACHV Stock Holding History

Guggenheim Capital’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7
Closed -$5K – 2799
2017
Q2 		$5K Hold
7
– – ﹤0.01% 2823
2017
Q1 		$7K Buy
7
+2
+40% +$2.43K ﹤0.01% 2825
2016
Q4 		$6K Hold
5
– – ﹤0.01% 2891
2016
Q3 		$6K Sell
5
-1
-17% -$1.59K ﹤0.01% 2875
2016
Q2 		$12K Hold
6
– – ﹤0.01% 2838
2016
Q1 		$8K Buy
+6
New +$9.78K ﹤0.01% 2879

Other funds holding ACHV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Guggenheim Capital's ACHV Position: Q3 2017 in Review

Guggenheim Capital sold out of Achieve Life Sciences (ACHV) in Q3 2017, closing a stake of 7 shares — an estimated $5K sold.

Guggenheim Capital first reported a position in ACHV in Q1 2016 and held it in 6 quarters. The position peaked at $12K in Q2 2016. 15 funds tracked by Wall St. Rank hold ACHV as of Q3 2017.

  • Guggenheim Capital reported no remaining Achieve Life Sciences position as of Q3 2017 after selling out during the quarter.
  • Guggenheim Capital sold 7 Achieve Life Sciences shares in Q3 2017, an estimated $5K.
  • Guggenheim Capital first reported a position in Achieve Life Sciences in Q1 2016 and held it in 6 quarters.
  • Guggenheim Capital's Achieve Life Sciences position peaked at $12K in Q2 2016.
  • 15 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2017.

Based on Guggenheim Capital's 13F filing for Q3 2017, filed 14 Nov 2017.